term,TopCut_highestMinuslogP_any,maximum_MinuslogP_any,sum_MinuslogP_any,times_significant_any,FirstTopCut_significant_any,PEBBA_score_any
Fertilization,850,0.11181046234945326,0.8949453766838034,0.0,0,0.027017474455731067
Reproduction,850,0.11181046234945326,0.8949453766838034,0.0,0,0.027017474455731067
Miscellaneous transport and binding events,550,0.16113837166513037,1.3817274565240807,0.0,0,0.04448922781110374
Uptake and actions of bacterial toxins,650,0.47890406353456133,7.835031853165342,0.0,0,0.10720863309164942
Dopamine Neurotransmitter Release Cycle,1100,0.4070727544652085,3.4073893907601307,0.0,0,0.0774689144331156
Serotonin Neurotransmitter Release Cycle,1100,0.43820093537532995,3.920373726733768,0.0,0,0.08219474476613756
Norepinephrine Neurotransmitter Release Cycle,1100,0.46975816424667566,4.408467546933738,0.0,0,0.08683788463210433
Acetylcholine Neurotransmitter Release Cycle,1100,0.5849401560882612,5.643692553210917,0.0,0,0.10259423028512538
Glutamate Neurotransmitter Release Cycle,1100,0.4070727544652085,3.4073893907601307,0.0,0,0.0774689144331156
Neurotransmitter Release Cycle,1100,0.4820998732267599,4.814160611696906,0.0,0,0.08861428318437474
GABA synthesis release reuptake and degradation,1100,0.7214572683424347,7.138135224780907,0.034482758620689655,1100,0.11906444990341723
Na+slashCl_ dependent neurotransmitter transporters,100,-0.0,0.0,0.0,0,0.0
Amine compound SLC transporters,250,0.946644519664887,13.546920189584876,0.10344827586206896,250,0.2370887950194908
Transport of inorganic cationsslashanions and amino acidsslasholigopeptides,600,0.16137456354961635,0.691600757245622,0.0,0,0.04320254393415099
Amino acid transport across the plasma membrane,450,0.09194448174626399,0.5133828610788436,0.0,0,0.028143285819839003
Amino acid and oligopeptide SLC transporters,450,0.06192419792432878,0.2790179207488801,0.0,0,0.019237328702505423
Zinc transporters,1450,0.40658673954656366,2.899586381365389,0.0,0,0.06948597159104158
Metal ion SLC transporters,1450,0.255091828024281,1.5958805951581594,0.0,0,0.04683027674301255
Amino acid synthesis and interconversion transamination,550,0.16113837166513037,1.2219887843372408,0.0,0,0.04448922781110374
Transport of vitamins nucleosides and related molecules,1050,0.12768952690448432,1.543657976311641,0.0,0,0.028269560856908765
Disorders of transmembrane transporters,100,-0.0,0.0,0.0,0,0.0
Surfactant metabolism,1000,0.019744948441709532,0.04952059081899734,0.0,0,0.004697258377780652
ABC transporters in lipid homeostasis,100,-0.0,0.0,0.0,0,0.0
ABC_family proteins mediated transport,400,0.10019964914118873,0.5252431516335219,0.0,0,0.031781071315118904
Signaling by Retinoic Acid,700,0.30963868646268,3.8462382046804033,0.0,0,0.0730406352108457
RA biosynthesis pathway,700,0.11401648452116582,0.7847319501226581,0.0,0,0.02955680276778251
The canonical retinoid cycle in rods twilight vision,700,0.41218924690296777,4.984108259647207,0.0,0,0.09265608816516295
Visual phototransduction,100,0.25524120902537945,1.4150025866089224,0.0,0,0.11263519817546958
Retinoid metabolism and transport,700,0.05882381005446422,0.2807017852349501,0.0,0,0.01566950564679925
Metabolism of fat_soluble vitamins,700,0.03448876686188511,0.10549458942717369,0.0,0,0.009298716548745012
HS_GAG degradation,550,0.09167825973847765,0.5596393182029878,0.0,0,0.026187114653606014
Diseases associated with glycosaminoglycan metabolism,100,-0.0,0.0,0.0,0,0.0
Defective B3GALT6 causes EDSP2 and SEMDJL1,100,-0.0,0.0,0.0,0,0.0
Defective B4GALT7 causes EDS progeroid type,100,-0.0,0.0,0.0,0,0.0
Defective B3GAT3 causes JDSSDHD,100,-0.0,0.0,0.0,0,0.0
A tetrasaccharide linker sequence is required for GAG synthesis,100,-0.0,0.0,0.0,0,0.0
Heparan sulfateslashheparin HS_GAG metabolism,550,0.16534956599480685,0.8026136949352257,0.0,0,0.04555849573196912
HS_GAG biosynthesis,550,0.09891558365260214,0.5243435759014986,0.0,0,0.02815395414545573
Chondroitin sulfateslashdermatan sulfate metabolism,1300,0.04384142964281498,0.2245623582102703,0.0,0,0.009313605125383744
Chondroitin sulfate biosynthesis,1200,0.33645616550206686,2.540015169260494,0.0,0,0.06400006784845715
Keratan sulfate biosynthesis,1300,0.12842455886527984,0.6875045392667831,0.0,0,0.02616843976181991
Keratan sulfateslashkeratin metabolism,1300,0.06661885403998183,0.2999564541791095,0.0,0,0.013993609233311465
Diseases of glycosylation,600,0.036245573380354,0.09220561621804683,0.0,0,0.010319371867822157
Diseases associated with O_glycosylation of proteins,600,0.07686393932037425,0.42542799224889644,0.0,0,0.02144785638945269
Defective B3GALTL causes Peters_plus syndrome PpS,100,-0.0,0.0,0.0,0,0.0
O_glycosylation of TSR domain_containing proteins,300,0.3154229460920678,3.8096800454841087,0.0,0,0.0990170904104516
O_linked glycosylation of mucins,600,0.004488020467383741,0.004488020467383741,0.0,0,0.0012981526796926126
Termination of O_glycan biosynthesis,600,0.11154779675349863,0.796043747043455,0.0,0,0.030599123125491914
Defective GALNT12 causes colorectal cancer 1 CRCS1,600,0.4450870300071114,5.840681661973217,0.0,0,0.10414047272752222
Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis HFTC,600,0.4450870300071114,5.840681661973217,0.0,0,0.10414047272752222
Defective C1GALT1C1 causes Tn polyagglutination syndrome TNPS,600,0.2785777732796359,2.9093569306603992,0.0,0,0.07048596056438719
Elastic fibre formation,150,0.3238135781752247,2.4355258228020027,0.0,0,0.12433556718294898
Molecules associated with elastic fibres,150,0.38077415994487945,3.445254911201261,0.0,0,0.14233892977856466
ECM proteoglycans,100,-0.0,0.0,0.0,0,0.0
Integrin cell surface interactions,100,-0.0,0.0,0.0,0,0.0
Syndecan interactions,1300,0.0283896613782629,0.08379268346323857,0.0,0,0.006077548572067578
Non_integrin membrane_ECM interactions,100,-0.0,0.0,0.0,0,0.0
Laminin interactions,100,-0.0,0.0,0.0,0,0.0
Assembly of collagen fibrils and other multimeric structures,1150,0.1979827743272363,1.5826623245496458,0.0,0,0.04090395502399542
Collagen formation,1150,0.07905296674065229,0.6970315590248819,0.0,0,0.017309533526485038
Collagen biosynthesis and modifying enzymes,750,0.010160365740511297,0.026248525707103953,0.0,0,0.0027039236663753056
Collagen degradation,100,-0.0,0.0,0.0,0,0.0
Activation of Matrix Metalloproteinases,100,-0.0,0.0,0.0,0,0.0
Hyaluronan metabolism,550,0.713863802361529,9.31970182348471,0.034482758620689655,550,0.15253215098107958
Activation of SMO,100,-0.0,0.0,0.0,0,0.0
Synthesis of glycosylphosphatidylinositol GPI,200,0.18487848559729475,1.0874021100481999,0.0,0,0.06991706181334217
Post_translational modification: synthesis of GPI_anchored proteins,200,0.15546228117615774,1.3712561149691989,0.0,0,0.05963873199969036
Common Pathway of Fibrin Clot Formation,1300,0.03909209493091602,0.14140817229319014,0.0,0,0.008324271481806584
Formation of Fibrin Clot Clotting Cascade,100,-0.0,0.0,0.0,0,0.0
Intrinsic Pathway of Fibrin Clot Formation,100,-0.0,0.0,0.0,0,0.0
Gamma carboxylation hypusine formation and arylsulfatase activation,600,0.6261578873323065,7.235178995539561,0.0,0,0.1349063252636962
Glycosphingolipid metabolism,1350,0.06181481005152305,0.1934935241716965,0.0,0,0.012824140244472728
Sphingolipid metabolism,600,0.10531470489274042,0.8935197970809526,0.0,0,0.028977842179746856
Sphingolipid de novo biosynthesis,550,0.2245203185759768,2.2411617628723457,0.0,0,0.060116041567891076
TNF receptor superfamily TNFSF members mediating non_canonical NF_kB pathway,1300,0.12842455886527984,1.4036682820139441,0.0,0,0.02616843976181991
TNFs bind their physiological receptors,550,0.46221459609956417,6.380537833161486,0.0,0,0.11063971483259526
Beta defensins,900,0.6078003330777336,6.355270041439393,0.0,0,0.11386315612906794
Defensins,1500,0.5113701178845514,5.106460100054273,0.0,0,0.0821522626086323
Depolymerisation of the Nuclear Lamina,950,0.5452190543762269,9.41609233480044,0.0,0,0.10295539140388799
Gap junction assembly,500,0.25355730711816704,3.248445345176375,0.0,0,0.0692089073070739
Gap junction trafficking,400,0.13111668824096,0.873985420914726,0.0,0,0.04096152687868626
Gap junction trafficking and regulation,400,0.11248421019276218,0.6939897090803266,0.0,0,0.035462847683409904
Golgi Associated Vesicle Biogenesis,150,0.8311292431693157,12.577421142586973,0.034482758620689655,150,0.25371126761389684
trans_Golgi Network Vesicle Budding,150,0.6823592150968385,8.677873967932051,0.0,0,0.22230720639941526
Clathrin derived vesicle budding,150,0.6823592150968385,8.677873967932051,0.0,0,0.22230720639941526
Lysosome Vesicle Biogenesis,1300,0.03935317302690389,0.13036291119197926,0.0,0,0.008378778778383812
Nef_mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,100,0.3908663502104107,1.7865024306262398,0.0,0,0.16176471992703173
The role of Nef in HIV_1 replication and disease pathogenesis,150,0.720740039592169,7.488997965837953,0.034482758620689655,150,0.23086144992688357
Trafficking of GluR2_containing AMPA receptors,1300,0.24374309256539695,2.317519909245668,0.0,0,0.04696746233909141
Trafficking of AMPA receptors,1300,0.12842455886527984,1.1722205324387338,0.0,0,0.02616843976181991
Glutamate Binding Activation of AMPA Receptors and Synaptic Plasticity,1300,0.12842455886527984,1.1722205324387338,0.0,0,0.02616843976181991
EGFR downregulation,100,0.9279133068924982,8.854430572714906,0.06896551724137931,0,0.30231105876117875
WNT5A_dependent internalization of FZD4,1300,0.12842455886527984,1.1722205324387338,0.0,0,0.02616843976181991
Recycling pathway of L1,100,0.3467513152449345,1.5245951068949475,0.0,0,0.14650943908731479
L1CAM interactions,1350,0.15202704691290755,1.2508519425880686,0.0,0,0.030172844019898767
Interaction between L1 and Ankyrins,900,0.33496549544592713,3.457110123046314,0.0,0,0.07115930769998158
Biosynthesis of the N_glycan precursor dolichol lipid_linked oligosaccharide LLO and transfer to a nascent protein,1300,0.0283896613782629,0.07549875683700484,0.0,0,0.006077548572067578
Synthesis of substrates in N_glycan biosythesis,1300,0.0283896613782629,0.06860847782845456,0.0,0,0.006077548572067578
Sialic acid metabolism,100,-0.0,0.0,0.0,0,0.0
N_Glycan antennae elongation,1300,0.0283896613782629,0.09112653167826835,0.0,0,0.006077548572067578
N_glycan antennae elongation in the medialslashtrans_Golgi,100,-0.0,0.0,0.0,0,0.0
Intra_Golgi traffic,800,0.13533556342792089,0.9354305190137335,0.0,0,0.03306246197406168
Retrograde transport at the Trans_Golgi_Network,100,0.6098445977309288,9.87397255087946,0.0,0,0.22828234320313961
COPI_dependent Golgi_to_ER retrograde traffic,750,0.23533157575019345,2.082657417728542,0.0,0,0.05608798047757334
Kinesins,400,0.07886334576942171,0.415321144115496,0.0,0,0.025277930987228563
COPI_independent Golgi_to_ER retrograde traffic,100,-0.0,0.0,0.0,0,0.0
COPI_mediated anterograde transport,900,0.3565247693479334,6.025050307640771,0.0,0,0.07497371747317572
COPII Coat Protein 2 Mediated Vesicle Transport,1450,0.6013347552220079,7.7370863563257455,0.0,0,0.09399564641794814
Cargo concentration in the ER,750,0.5173861029060582,7.274911418692756,0.0,0,0.10804098382581248
Intraflagellar transport,200,0.18487848559729475,1.1288553593276973,0.0,0,0.06991706181334217
Antigen Presentation: Folding assembly and peptide loading of class I MHC,1450,1.3009264917294894,21.033698719481148,0.4482758620689655,0,0.1513597670148285
N_glycan trimming in the ER and CalnexinslashCalreticulin cycle,150,0.26678072108813183,3.1293173652127737,0.0,0,0.10525207504842282
Calnexinslashcalreticulin cycle,150,0.2771859696237269,3.510863972625528,0.0,0,0.10881538283530282
XBP1S activates chaperone genes,1000,0.06722970637810956,0.5812672308456228,0.0,0,0.015621157357438253
IRE1alpha activates chaperones,1000,0.05420038380857684,0.431328378124883,0.0,0,0.01267520546185001
Unfolded Protein Response UPR,100,0.4278853406662052,3.6452592423146823,0.0,0,0.1740569223269593
PERK regulates gene expression,100,0.2929220789219164,2.3598628664893355,0.0,0,0.12695986309421659
ATF4 activates genes,100,0.3321793283193318,3.190091551063993,0.0,0,0.14132066570264257
KSRP KHSRP binds and destabilizes mRNA,1300,0.1112860066141408,0.7656456342066843,0.0,0,0.022867441175626637
Tristetraprolin TTP ZFP36 binds and destabilizes mRNA,850,0.5867070027416519,7.716101216954795,0.0,0,0.11335641290590556
Butyrate Response Factor 1 BRF1 binds and destabilizes mRNA,850,0.5867070027416519,7.716101216954795,0.0,0,0.11335641290590556
mRNA decay by 5  to 3  exoribonuclease,900,0.6851261894248214,9.72871732647646,0.0,0,0.12399334431699069
Deadenylation_dependent mRNA decay,900,0.6692073637924352,9.234083199283077,0.0,0,0.12197141566959421
Deadenylation of mRNA,700,0.4653466724065843,5.559773825791333,0.0,0,0.10205924168465977
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,700,0.24109430192476464,2.170803597206111,0.0,0,0.058762229844182154
TP53 Regulates Transcription of Cell Cycle Genes,700,0.1848968053830711,1.6436919769459057,0.0,0,0.04630319838929435
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,400,0.1028760715687904,0.5621414326017453,0.0,0,0.032587073470024465
TP53 Regulates Transcription of Cell Death Genes,150,0.13389006301949574,0.65491972894348,0.0,0,0.056327258883396125
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,1000,0.1704254887217434,1.264456781519127,0.0,0,0.03764623355369493
Intrinsic Pathway for Apoptosis,1500,0.5719381344594814,6.763055148068388,0.0,0,0.08938457885470814
Activation of BH3_only proteins,1500,0.5832128457680962,4.152805750794461,0.0,0,0.09068317752965734
Activation of BAD and translocation to mitochondria,1500,0.44504991817062717,2.544337721284452,0.0,0,0.0737141267319134
Translocation of GLUT4 to the plasma membrane,1500,0.46462989457204507,4.925366357026319,0.0,0,0.07626383042372072
TP53 Regulates Metabolic Genes,1500,0.5719381344594814,6.865818314085281,0.0,0,0.08938457885470814
PI3K Cascade,900,0.9589008444313384,16.219807420076826,0.3793103448275862,550,0.15417150594940704
mTORC1_mediated signalling,900,0.5743556636151291,6.113593924998597,0.0,0,0.10923311078453024
PKB_mediated events,1000,1.0944802693653277,16.59695768290275,0.3448275862068966,800,0.15983712084971763
mTOR signalling,1000,1.1292092475453746,17.339098045419075,0.41379310344827586,650,0.1625819463444112
Energy dependent regulation of mTOR by LKB1_AMPK,850,0.7507839867676688,11.901652860285152,0.06896551724137931,850,0.1348504341099941
Macroautophagy,500,1.0099901834140645,19.03166442628543,0.4827586206896552,400,0.19646603515270455
PD_1 signaling,600,1.4422762724403313,26.99534214215532,0.9310344827586207,150,0.22136924503042818
Phosphorylation of CD3 and TCR zeta chains,250,1.1946630595679277,16.021130549721356,0.3103448275862069,150,0.27011101739508436
Translocation of ZAP_70 to Immunological synapse,250,1.3693018916254394,22.66359661170496,0.6551724137931034,150,0.28890952149667204
Generation of second messenger molecules,250,1.4633423316977634,22.447058873734512,0.6206896551724138,200,0.29775176416016885
Costimulation by the CD28 family,600,1.9233949334152707,32.76965397672788,0.9655172413793104,150,0.24754093460385476
CD28 co_stimulation,550,0.8994782003462041,11.41733250770441,0.06896551724137931,550,0.17733371386425753
CD28 dependent PI3KslashAkt signaling,550,1.2387330349546952,16.45644303114778,0.2413793103448276,550,0.21231831787773617
VEGFR2 mediated vascular permeability,250,0.15911997711029927,1.4198471259111387,0.0,0,0.05699266277952576
Constitutive Signaling by AKT1 E17K in Cancer,250,0.4570628815020513,3.535813547572762,0.0,0,0.14213085702342057
Regulation of TP53 Activity through Acetylation,850,0.6879750715870795,11.178902012848427,0.0,0,0.12703621551256208
Regulation of gene expression in beta cells,100,-0.0,0.0,0.0,0,0.0
Regulation of beta_cell development,100,-0.0,0.0,0.0,0,0.0
Regulation of innate immune responses to cytosolic DNA,100,1.219704973847409,17.324472606300436,0.3448275862068966,0,0.35234135980298265
STING mediated induction of host immune responses,100,-0.0,0.0,0.0,0,0.0
HSF1 activation,1200,0.3742629187920211,5.362209131738443,0.0,0,0.06993656806430482
Attenuation phase,1000,0.4529713916208332,5.1694117781397795,0.0,0,0.08751546844986045
HSF1_dependent transactivation,1000,0.3258141700844782,3.3176764476837066,0.0,0,0.06680492985090719
Cellular response to heat stress,1300,0.22796940032343974,1.8401282722783145,0.0,0,0.04426210163655837
Regulation of HSF1_mediated heat shock response,1300,0.17299157529823583,1.045964788458484,0.0,0,0.034492135531804476
SUMOylation of DNA damage response and repair proteins,1450,0.3733580223928118,3.727748013882546,0.0,0,0.06480628799555277
SUMO E3 ligases SUMOylate target proteins,1300,0.4632332784442932,7.78457618252613,0.0,0,0.08050158426790543
Transcriptional regulation by small RNAs,100,0.5440777805065495,2.2017928724140563,0.0,0,0.20981161430707745
Nuclear Envelope Breakdown,1300,0.13097319192065568,0.9525243164053346,0.0,0,0.026654509184173964
Metabolism of non_coding RNA,1450,0.3245082475002495,3.4869781689080988,0.0,0,0.05763806015375959
snRNP Assembly,1450,0.3245082475002495,3.4869781689080988,0.0,0,0.05763806015375959
SUMOylation of RNA binding proteins,1300,0.2813520303061054,2.4159410056766637,0.0,0,0.05324822066454178
Hexose transport,100,-0.0,0.0,0.0,0,0.0
Glucose transport,100,-0.0,0.0,0.0,0,0.0
SUMOylation of DNA replication proteins,100,-0.0,0.0,0.0,0,0.0
Viral Messenger RNA Synthesis,100,0.1858050641857149,1.0411453689991392,0.0,0,0.08478226959126922
Transport of Mature mRNA Derived from an Intronless Transcript,100,-0.0,0.0,0.0,0,0.0
Transport of Mature mRNAs Derived from Intronless Transcripts,100,-0.0,0.0,0.0,0,0.0
Transport of the SLBP Dependant Mature mRNA,100,-0.0,0.0,0.0,0,0.0
Transport of the SLBP independent Mature mRNA,100,-0.0,0.0,0.0,0,0.0
Nuclear Pore Complex NPC Disassembly,100,-0.0,0.0,0.0,0,0.0
Nuclear import of Rev protein,100,-0.0,0.0,0.0,0,0.0
Interactions of Rev with host cellular proteins,100,-0.0,0.0,0.0,0,0.0
Rev_mediated nuclear export of HIV RNA,100,-0.0,0.0,0.0,0,0.0
NEPslashNS2 Interacts with the Cellular Export Machinery,100,-0.0,0.0,0.0,0,0.0
Export of Viral Ribonucleoproteins from Nucleus,100,-0.0,0.0,0.0,0,0.0
Regulation of Glucokinase by Glucokinase Regulatory Protein,100,-0.0,0.0,0.0,0,0.0
Transport of Ribonucleoproteins into the Host Nucleus,1300,0.008995476789860632,0.013689659660455131,0.0,0,0.0019444227189037862
Vpr_mediated nuclear import of PICs,1300,0.006637757050820758,0.00849344226806775,0.0,0,0.001436478590308286
Interactions of Vpr with host cellular proteins,1300,0.03935317302690389,0.1481308784428292,0.0,0,0.008378778778383812
Host Interactions with Influenza Factors,1300,0.0283896613782629,0.05622544082086308,0.0,0,0.006077548572067578
NS1 Mediated Effects on Host Pathways,1300,0.0283896613782629,0.07114718591028825,0.0,0,0.006077548572067578
ISG15 antiviral mechanism,1100,0.4679934478863006,8.450653482224652,0.0,0,0.08658208466016305
Antiviral mechanism by IFN_stimulated genes,1100,0.4679934478863006,8.450653482224652,0.0,0,0.08658208466016305
tRNA processing in the nucleus,1300,0.24674202646370907,1.9057221339867367,0.0,0,0.0474770019414705
Cleavage of Growing Transcript in the Termination Region,100,0.5331886306465249,6.206849238318082,0.0,0,0.20663444253182456
RNA Polymerase II Transcription Termination,100,0.5331886306465249,6.206849238318082,0.0,0,0.20663444253182456
Post_Elongation Processing of the Transcript,100,0.5331886306465249,6.206849238318082,0.0,0,0.20663444253182456
mRNA 3 _end processing,100,0.5579674729493793,6.054993644000954,0.0,0,0.21381437879888748
Post_Elongation Processing of Intron_Containing pre_mRNA,100,0.5579674729493793,6.054993644000954,0.0,0,0.21381437879888748
Transport of Mature Transcript to Cytoplasm,100,0.46013356198291944,1.664446053113557,0.0,0,0.18440033217906543
Transport of Mature mRNA derived from an Intron_Containing Transcript,100,0.49335148962891956,1.562261634071193,0.0,0,0.194711690002478
mRNA Splicing _ Minor Pathway,150,1.1073674855692404,18.657325335093336,0.4482758620689655,0,0.3009658931537907
Post_Elongation Processing of Intronless pre_mRNA,1150,0.3901165105318548,3.026290658260194,0.0,0,0.07356180097623341
Processing of Capped Intronless Pre_mRNA,1150,0.3901165105318548,3.026290658260194,0.0,0,0.07356180097623341
Processing of Intronless Pre_mRNAs,1150,0.36510447062136614,2.5954251232424754,0.0,0,0.06965711128529069
rRNA modification in the nucleus,500,0.19606636223116225,1.4886479537966049,0.0,0,0.05501810076786383
Selenocysteine synthesis,1450,5.218349878137921,81.56325944448386,1.0,0,0.20686506010612254
Viral mRNA Translation,1450,4.849563420924242,74.33252051017428,1.0,0,0.20636264875961668
Peptide chain elongation,1450,5.551941963998515,90.47135483135895,1.0,0,0.20718460674276662
Eukaryotic Translation Elongation,1450,6.111914934985636,106.01367752586795,1.0,0,0.20753062418255575
Eukaryotic Translation Termination,1450,5.17854288836915,82.55657677048276,1.0,0,0.20681931156800776
Nonsense Mediated Decay NMD independent of the Exon Junction Complex EJC,1450,4.864304330031904,76.29589403381843,1.0,0,0.20638648481620708
Formation of a pool of free 40S subunits,1450,5.451965747974196,88.92027262092923,1.0,0,0.2070997560994662
Formation of the ternary complex and subsequently the 43S complex,1350,1.4091515622403812,24.241335155320293,0.7931034482758621,0,0.1616627214811019
Ribosomal scanning and start codon recognition,1350,2.1275578927180274,39.37708391743092,1.0,0,0.18845270098356492
Translation initiation complex formation,1350,1.627410311842778,30.402242907287782,0.9655172413793104,0,0.17191314474708574
Activation of the mRNA upon binding of the cap_binding complex and eIFs and subsequent binding to 43S,1350,1.6157870050009804,29.866861795405047,0.9655172413793104,0,0.1714218181311686
Formation of Senescence_Associated Heterochromatin Foci SAHF,1300,0.006637757050820758,0.010873486689618477,0.0,0,0.001436478590308286
DNA DamageslashTelomere Stress Induced Senescence,200,0.036280632347080115,0.0511794950530189,0.0,0,0.014758585719386718
Oxidative Stress Induced Senescence,100,0.9174257800263372,11.041760203214062,0.06896551724137931,0,0.3002268808457359
Senescence_Associated Secretory Phenotype SASP,100,1.4652336853355223,10.086583456538591,0.10344827586206896,0,0.3844880008758407
Amyloid fiber formation,100,1.277593384569632,11.620325282566986,0.10344827586206896,0,0.360646382437551
Deposition of new CENPA_containing nucleosomes at the centromere,200,0.5955949062800668,4.383333520551845,0.0,0,0.18588474175497982
Nucleosome assembly,200,0.5955949062800668,4.383333520551845,0.0,0,0.18588474175497982
Chromosome Maintenance,200,0.6089228120508857,6.3552987262474065,0.0,0,0.18890769718047096
Telomere Maintenance,1400,0.09966260455189027,0.9161592335294012,0.0,0,0.020005081492247053
Meiotic recombination,100,0.20594785415390077,0.5089680708839384,0.0,0,0.09306224229811533
Meiosis,100,0.08902934763221108,0.11888193495321381,0.0,0,0.0425906372915022
Meiotic synapsis,1450,9.378691037146673e-05,9.378691037146673e-05,0.0,0,1.9505974503390025e-05
Packaging Of Telomere Ends,100,-0.0,0.0,0.0,0,0.0
SIRT1 negatively regulates rRNA Expression,100,0.3321793283193318,1.2732262654710556,0.0,0,0.14132066570264257
Activated PKN1 stimulates transcription of AR androgen receptor regulated genes KLK2 and KLK3,100,0.3612633268474407,2.814629324182391,0.0,0,0.15160225532651328
RNA Polymerase I Promoter Opening,100,0.3753453886262265,1.946089671407723,0.0,0,0.1564740310595324
DNA methylation,100,0.3908663502104107,1.7035169054167154,0.0,0,0.16176471992703173
PRC2 methylates histones and DNA,200,0.539026680692172,3.57569347430095,0.0,0,0.17259627643206077
Condensation of Prophase Chromosomes,100,0.3467513152449345,1.3834579236650861,0.0,0,0.14650943908731479
ERCC6 CSB and EHMT2 G9a positively regulate rRNA expression,200,0.8982903047468491,8.125457392699536,0.10344827586206896,0,0.245518724908215
RHO GTPases activate PKNs,250,0.5706806333031993,6.000283167435756,0.0,0,0.1684757676402251
Formation of the beta_catenin:TCF transactivating complex,200,0.31800840320061313,1.6877201305010316,0.0,0,0.11283315196197853
Activation of anterior HOX genes in hindbrain development during early embryogenesis,550,1.026424261972764,15.294649817997984,0.2413793103448276,200,0.1918308858677088
Activation of HOX genes during differentiation,550,1.026424261972764,15.294649817997984,0.2413793103448276,200,0.1918308858677088
B_WICH complex positively regulates rRNA expression,100,0.18010341566745552,0.4877297977858469,0.0,0,0.08240808207438838
Positive epigenetic regulation of rRNA expression,200,0.5955949062800668,4.285127582563026,0.0,0,0.18588474175497982
Negative epigenetic regulation of rRNA expression,100,0.5344480745768527,2.278572528484457,0.0,0,0.20700368743211284
NoRC negatively regulates rRNA expression,100,0.552805934792248,2.63735417749475,0.0,0,0.21233340202391787
RNA Polymerase I Chain Elongation,100,0.1858050641857149,0.3871245253763029,0.0,0,0.08478226959126922
RNA Polymerase I Transcription,200,0.5801279167318374,3.8883909218128148,0.0,0,0.18232572962211652
RNA Polymerase I Promoter Clearance,200,0.5818706265583558,4.072319299601694,0.0,0,0.18272949090533727
RNA Polymerase I Transcription Initiation,200,0.32910566976444794,2.5452052608951194,0.0,0,0.11615916177178338
RNA Polymerase I Promoter Escape,100,-0.0,0.0,0.0,0,0.0
RNA Polymerase I Transcription Termination,100,-0.0,0.0,0.0,0,0.0
RMTs methylate histone arginines,1200,0.3742629187920211,5.072266687713387,0.0,0,0.06993656806430482
HDACs deacetylate histones,200,0.6658988961885551,4.0796054626427,0.0,0,0.20138588842216343
PKMTs methylate histone lysines,1300,0.19447873442552135,1.1858485065907787,0.0,0,0.03837462752743014
HDMs demethylate histones,650,0.1821975001726621,1.715726738902353,0.0,0,0.04692571401366435
Transcriptional regulation of pluripotent stem cells,100,0.3612633268474407,3.9548486286371585,0.0,0,0.15160225532651328
RNA Polymerase III Transcription Termination,550,0.35632533334237804,3.8335444740421463,0.0,0,0.08960735492642326
RNA Polymerase III Chain Elongation,550,0.46221459609956417,5.257503401015646,0.0,0,0.11063971483259526
RNA Polymerase III Transcription Initiation From Type 2 Promoter,500,0.2641885880609426,3.93887349829826,0.0,0,0.07174487030014857
RNA Polymerase III Transcription Initiation From Type 1 Promoter,500,0.25355730711816704,3.5174376599398847,0.0,0,0.0692089073070739
RNA Polymerase III Abortive And Retractive Initiation,1500,0.44504991817062717,6.287413954855802,0.0,0,0.0737141267319134
RNA Polymerase III Transcription,1500,0.44504991817062717,6.287413954855802,0.0,0,0.0737141267319134
RNA Polymerase III Transcription Initiation,550,0.45522720397819383,7.4601872514704635,0.0,0,0.10931941389224317
RNA Polymerase III Transcription Initiation From Type 3 Promoter,550,0.6270492819958051,9.488068556258831,0.0,0,0.1392542307232682
RNA polymerase II transcribes snRNA genes,550,0.9008871074992104,12.617706537639718,0.13793103448275862,200,0.17750491827117856
PIWI_interacting RNA piRNA biogenesis,550,0.7125800833933342,9.992208286292309,0.06896551724137931,400,0.15234409007556868
MicroRNA miRNA biogenesis,650,0.8238987562203525,11.639552813651576,0.06896551724137931,650,0.15812948170411667
FGFR2 alternative splicing,550,0.5913196740978677,6.5702657716613935,0.0,0,0.13344574692244482
Signaling by FGFR2 IIIa TM,100,0.4118899395613672,5.331015514041036,0.0,0,0.1688014121179624
Abortive elongation of HIV_1 transcript in the absence of Tat,400,0.6076065745780364,8.793508941530668,0.0,0,0.15178236787044266
Formation of the Early Elongation Complex,400,0.4474740451101863,5.867648023146886,0.0,0,0.12025306418008685
Formation of the HIV_1 Early Elongation Complex,400,0.4474740451101863,5.867648023146886,0.0,0,0.12025306418008685
Formation of HIV elongation complex in the absence of HIV Tat,1450,0.6738682171133656,8.567395135775794,0.0,0,0.10197141576675701
RNA Polymerase II Transcription Elongation,1450,0.6738682171133656,8.567395135775794,0.0,0,0.10197141576675701
Formation of RNA Pol II elongation complex,1450,0.6738682171133656,8.567395135775794,0.0,0,0.10197141576675701
HIV Transcription Elongation,1450,0.7055150157780746,8.989190912582696,0.034482758620689655,1450,0.10527408006939828
Tat_mediated elongation of the HIV_1 transcript,1450,0.7055150157780746,8.989190912582696,0.034482758620689655,1450,0.10527408006939828
Formation of HIV_1 elongation complex containing HIV_1 Tat,1450,0.7055150157780746,8.989190912582696,0.034482758620689655,1450,0.10527408006939828
Pausing and recovery of Tat_mediated HIV elongation,1400,0.8877108426813412,13.416848215744631,0.20689655172413793,550,0.12409228816867934
Tat_mediated HIV elongation arrest and recovery,1400,0.8877108426813412,13.416848215744631,0.20689655172413793,550,0.12409228816867934
HIV elongation arrest and recovery,1400,0.8620714681698978,12.96650283926293,0.13793103448275862,550,0.12183789972138918
Pausing and recovery of HIV elongation,1400,0.8620714681698978,12.96650283926293,0.13793103448275862,550,0.12183789972138918
Elongation arrest and recovery,1400,0.8620714681698978,12.96650283926293,0.13793103448275862,550,0.12183789972138918
TP53 Regulates Transcription of DNA Repair Genes,1450,0.4573607942276279,4.718945508837499,0.0,0,0.07634291335738326
Transcription of the HIV genome,1450,0.3733580223928118,3.2376181618822963,0.0,0,0.06480628799555277
RNA Polymerase II Pre_transcription Events,1450,0.40482532681837013,3.574104190933326,0.0,0,0.06924179103213696
RNA Polymerase II HIV Promoter Escape,100,0.18568842340090402,0.9998352140565081,0.0,0,0.08473383544468344
RNA Polymerase II Promoter Escape,100,0.18568842340090402,0.9998352140565081,0.0,0,0.08473383544468344
RNA Polymerase II Transcription Initiation And Promoter Clearance,100,0.18568842340090402,0.9998352140565081,0.0,0,0.08473383544468344
RNA Polymerase II Transcription Initiation,100,0.18568842340090402,0.9998352140565081,0.0,0,0.08473383544468344
RNA Polymerase II Transcription Pre_Initiation And Promoter Opening,100,0.18568842340090402,0.9998352140565081,0.0,0,0.08473383544468344
HIV Transcription Initiation,100,0.18568842340090402,0.9998352140565081,0.0,0,0.08473383544468344
RNA Pol II CTD phosphorylation and interaction with CE,100,0.3065574101332662,2.9324959711804888,0.0,0,0.132011867764474
mRNA Capping,100,0.2817007627368496,2.4930170663091835,0.0,0,0.12275028745028743
Formation of TC_NER Pre_Incision Complex,750,2.0976340730694902,40.083192830940135,0.9310344827586207,0,0.23464679431646226
Dual incision in TC_NER,500,1.4634799506266294,27.109168162509953,0.7241379310344828,0,0.2375013432401304
Gap_filling DNA repair synthesis and ligation in TC_NER,500,1.4634799506266294,23.749195204833647,0.5862068965517241,0,0.2375013432401304
Transcription_Coupled Nucleotide Excision Repair TC_NER,500,1.4278888969000687,24.54329024297554,0.6206896551724138,0,0.23491018841011668
Global Genome Nucleotide Excision Repair GG_NER,100,0.8929716373587662,14.600648061444465,0.13793103448275862,0,0.29528137792230413
Formation of Incision Complex in GG_NER,100,1.2776600252324837,22.129252984922058,0.5862068965517241,0,0.36065566874556987
DNA Damage Recognition in GG_NER,500,0.9034064162529382,16.732692210556184,0.2413793103448276,300,0.18380730371478604
Processing of DNA double_strand break ends,700,0.9562211688942388,17.78399283189879,0.3103448275862069,300,0.16886985335234905
G2slashM DNA damage checkpoint,700,0.5668267084405515,9.202339530865732,0.0,0,0.1186798267105145
Nonhomologous End_Joining NHEJ,700,0.6221352270932252,8.428705643511613,0.0,0,0.12705281600337265
Recruitment and ATM_mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,700,1.0744677601231765,20.760905716811987,0.4827586206896552,200,0.18062684146209668
DNA Double Strand Break Response,700,1.0364037783758435,20.13438578895093,0.4827586206896552,200,0.17699285367848477
HDR through Single Strand Annealing SSA,300,0.33936346950618873,2.513417956775982,0.0,0,0.10533349844744272
Presynaptic phase of homologous DNA pairing and strand exchange,300,0.33936346950618873,2.513417956775982,0.0,0,0.10533349844744272
Homologous DNA Pairing and Strand Exchange,300,0.33936346950618873,2.513417956775982,0.0,0,0.10533349844744272
HDR through Homologous Recombination HRR,550,0.8823188996867062,12.86549291502434,0.1724137931034483,200,0.17522911429772176
Resolution of D_loop Structures through Holliday Junction Intermediates,200,0.18487848559729475,1.045869834118173,0.0,0,0.06991706181334217
Resolution of D_Loop Structures,200,0.18487848559729475,0.9227127818802695,0.0,0,0.06991706181334217
Resolution of D_loop Structures through Synthesis_Dependent Strand Annealing SDSA,200,0.20080377335744862,1.3759996887126589,0.0,0,0.07535665415992486
Regulation of TP53 Activity through Phosphorylation,500,0.8799324682614982,9.991466249645429,0.13793103448275862,400,0.18083336951826826
Regulation of TP53 Expression and Degradation,100,1.4523090026424421,20.295002798566767,0.4827586206896552,0,0.38298535524865013
Regulation of TP53 Degradation,100,1.4523090026424421,20.805618094258982,0.5172413793103449,0,0.38298535524865013
Regulation of TP53 Activity through Methylation,100,1.1023264162917261,14.394238614544705,0.20689655172413793,0,0.3339512064638218
Translesion Synthesis by POLH,100,1.1023264162917261,13.469505190918516,0.20689655172413793,0,0.3339512064638218
Translesion synthesis by POLK,100,1.1023264162917261,13.469505190918516,0.20689655172413793,0,0.3339512064638218
Translesion synthesis by REV1,100,1.1023264162917261,13.469505190918516,0.20689655172413793,0,0.3339512064638218
Translesion synthesis by POLI,100,1.1023264162917261,13.469505190918516,0.20689655172413793,0,0.3339512064638218
Termination of translesion DNA synthesis,100,0.9539156856404168,9.036629079127147,0.06896551724137931,0,0.3073851859060474
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,100,0.8455706387167068,6.343337065936519,0.034482758620689655,0,0.2853438469620673
DNA Damage Bypass,100,0.7293826566124202,8.361257392886241,0.034482758620689655,0,0.25889670736579695
Recognition of DNA damage by PCNA_containing replication complex,500,1.0099901834140645,16.474671539195736,0.27586206896551724,0,0.19646603515270455
Gap_filling DNA repair synthesis and ligation in GG_NER,100,1.0661433803516636,11.766731826537654,0.10344827586206896,0,0.32783303751993753
Dual Incision in GG_NER,700,0.8658182526059206,15.275732629106786,0.20689655172413793,0,0.15889532322961894
Base Excision Repair,1400,0.05213406054224892,0.13353439933742045,0.0,0,0.010713214394415927
Resolution of Abasic Sites AP sites,1400,0.05213406054224892,0.13353439933742045,0.0,0,0.010713214394415927
Resolution of AP sites via the multiple_nucleotide patch replacement pathway,100,-0.0,0.0,0.0,0,0.0
PCNA_Dependent Long Patch Base Excision Repair,100,-0.0,0.0,0.0,0,0.0
Extension of Telomeres,1450,0.4573607942276279,6.33315038407844,0.0,0,0.07634291335738326
Telomere C_strand Lagging Strand Synthesis,1400,0.2330293986882297,2.234971383560795,0.0,0,0.043839041384373896
Lagging Strand Synthesis,1400,0.2330293986882297,2.234971383560795,0.0,0,0.043839041384373896
DNA strand elongation,200,0.5814557424204996,5.236504723675482,0.0,0,0.18263343191062023
Mismatch Repair,200,0.20162620564061653,1.464356187273829,0.0,0,0.07563522645148886
Processive synthesis on the lagging strand,1450,0.3733580223928118,3.7278014871052845,0.0,0,0.06480628799555277
E2F mediated regulation of DNA replication,250,1.6077853511708264,24.783276095543517,0.5517241379310345,0,0.30981255451295936
G1slashS_Specific Transcription,100,-0.0,0.0,0.0,0,0.0
Association of licensing factors with the pre_replicative complex,100,1.277593384569632,18.232100433649435,0.41379310344827586,0,0.360646382437551
Activation of ATR in response to replication stress,100,0.9279133068924982,9.527211641797427,0.10344827586206896,0,0.30231105876117875
Activation of the pre_replicative complex,200,1.124191942318597,15.77234670923131,0.27586206896551724,0,0.2796293994957874
G0 and Early G1,550,0.429773376867024,4.844929181030393,0.0,0,0.10443101914824143
Signal transduction by L1,100,-0.0,0.0,0.0,0,0.0
RAF_independent MAPK1slash3 activation,1100,0.21871890705269215,2.0789891869183093,0.0,0,0.045510659734988246
Interleukin_6 family signaling,1100,0.4820998732267599,4.701905920367493,0.0,0,0.08861428318437474
IL_6_type cytokine receptor ligand interactions,1100,0.4820998732267599,6.171054969406709,0.0,0,0.08861428318437474
Regulation of IFNA signaling,1100,0.5849401560882612,7.1453856828042275,0.0,0,0.10259423028512538
Interferon alphaslashbeta signaling,1200,0.6329344315581724,9.552676584169195,0.0,0,0.10505333498419629
Interferon gamma signaling,1250,1.1138691322678749,20.16711659553579,0.4482758620689655,0,0.14810024496912363
Growth hormone receptor signaling,550,0.7125800833933342,6.88613185819567,0.034482758620689655,550,0.15234409007556868
Prolactin receptor signaling,1100,0.296261619440655,3.333167594790328,0.0,0,0.059399912716909704
Nuclear signaling by ERBB4,550,0.05384010471981915,0.49193661543956174,0.0,0,0.015669098407587255
NOTCH1 Intracellular Domain Regulates Transcription,100,1.1964103951113212,18.251436379980056,0.3793103448275862,0,0.3488613385324894
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,100,1.1023264162917261,15.506289066973098,0.27586206896551724,0,0.3339512064638218
Signaling by NOTCH1 in Cancer,100,1.1023264162917261,15.506289066973098,0.27586206896551724,0,0.3339512064638218
Signaling by NOTCH1 PEST Domain Mutants in Cancer,100,1.1023264162917261,15.506289066973098,0.27586206896551724,0,0.3339512064638218
Constitutive Signaling by NOTCH1 PEST Domain Mutants,100,1.1023264162917261,15.506289066973098,0.27586206896551724,0,0.3339512064638218
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,100,1.1023264162917261,15.506289066973098,0.27586206896551724,0,0.3339512064638218
Signaling by NOTCH1,100,2.096302076733971,22.375449736729458,0.4482758620689655,0,0.43854494948266165
Constitutive Signaling by NOTCH1 HD Domain Mutants,100,1.219704973847409,17.324472606300436,0.3448275862068966,0,0.35234135980298265
Signaling by NOTCH1 HD Domain Mutants in Cancer,100,1.219704973847409,17.324472606300436,0.3448275862068966,0,0.35234135980298265
Activated NOTCH1 Transmits Signal to the Nucleus,100,2.281564956897895,25.444148678320996,0.5517241379310345,0,0.4489378692365007
NOTCH2 Activation and Transmission of Signal to the Nucleus,100,1.1023264162917261,12.614477574772542,0.13793103448275862,0,0.3339512064638218
Signaling by NOTCH2,500,1.2339635432599088,18.283350662118075,0.41379310344827586,0,0.21905091260245632
Pre_NOTCH Transcription and Translation,650,0.6010435343796512,5.726852168761883,0.0,0,0.12727413078300262
Pre_NOTCH Expression and Processing,650,0.5627955993986344,5.147511461991617,0.0,0,0.12125211855363048
Pre_NOTCH Processing in Golgi,100,-0.0,0.0,0.0,0,0.0
NRIF signals cell death from the nucleus,100,1.1599451481722467,17.788424906678134,0.27586206896551724,0,0.3432483116778964
p75NTR signals via NF_kB,100,1.1023264162917261,14.394238614544705,0.20689655172413793,0,0.3339512064638218
TRAF6 mediated induction of TAK1 complex,500,1.2951222640629605,21.296430523811033,0.5172413793103449,0,0.22438824726055467
Budding and maturation of HIV virion,650,2.40360582566729,47.18721829619115,1.0,0,0.2562631555090507
Endosomal Sorting Complex Required For Transport ESCRT,650,1.767277938371298,34.65247839621733,0.9655172413793104,0,0.23361049256720673
PinkslashParkin Mediated Mitophagy,100,0.9815047682601878,14.547305740959688,0.20689655172413793,0,0.31262661633863803
Mitophagy,100,0.9815047682601878,14.547305740959688,0.20689655172413793,0,0.31262661633863803
Fanconi Anemia Pathway,550,2.1675194602615386,35.79614528811932,0.9310344827586207,0,0.2647186187526436
Oncogene Induced Senescence,150,1.6431927720461,24.32147397544411,0.5517241379310345,0,0.3625756438383138
G1 Phase,100,1.376341559481885,17.24638404197339,0.3103448275862069,0,0.3737496880630289
Cyclin D associated events in G1,100,1.376341559481885,17.24638404197339,0.3103448275862069,0,0.3737496880630289
SMAD2slashSMAD3:SMAD4 heterotrimer regulates transcription,100,1.4523090026424421,22.419330492850623,0.4827586206896552,0,0.38298535524865013
Transcriptional activity of SMAD2slashSMAD3:SMAD4 heterotrimer,550,1.3746304686974036,24.315327238251758,0.6551724137931034,0,0.2233245231996184
Signaling by TGF_beta Receptor Complex,100,1.4294583506264955,22.77871212373906,0.5517241379310345,0,0.3802807105586947
Downregulation of SMAD2slash3:SMAD4 transcriptional activity,500,1.0099901834140645,17.548962094821647,0.27586206896551724,0,0.19646603515270455
Oxygen_dependent proline hydroxylation of Hypoxia_inducible Factor Alpha,100,1.6959231987047296,22.268759875013927,0.5172413793103449,0,0.40828509566317556
Regulation of Hypoxia_inducible Factor HIF by oxygen,250,1.571744446329412,24.00406890616803,0.5517241379310345,0,0.3069642809199148
Cellular response to hypoxia,250,1.571744446329412,24.00406890616803,0.5517241379310345,0,0.3069642809199148
Glycogen synthesis,100,1.277593384569632,18.232100433649435,0.41379310344827586,0,0.360646382437551
Glycogen breakdown glycogenolysis,1100,0.1773067610112862,1.1773294022031175,0.0,0,0.03763986497030816
Glucose metabolism,100,1.0021307789049758,5.489335994494391,0.06896551724137931,0,0.3164517970238271
Gluconeogenesis,100,-0.0,0.0,0.0,0,0.0
Glycolysis,100,0.2817007627368496,0.9051013834228814,0.0,0,0.12275028745028743
DARPP_32 events,850,1.116060442800633,17.14685215870334,0.4827586206896552,550,0.17173704581895644
Negative regulation of MAPK pathway,250,1.6067174458983928,22.907575634028788,0.5517241379310345,0,0.30972962655456043
RAF activation,250,0.45496867193878293,4.821152831518201,0.0,0,0.14161661955383018
CTLA4 inhibitory signaling,550,0.7401591208549954,10.40797992586822,0.034482758620689655,550,0.15633168878794027
Platelet sensitization by LDL,100,0.436583784336003,5.059088059647813,0.0,0,0.17687982460038953
S33 mutants of beta_catenin aren t phosphorylated,100,0.46013356198291944,2.6001409589521733,0.0,0,0.18440033217906543
S45 mutants of beta_catenin aren t phosphorylated,100,0.46013356198291944,2.6001409589521733,0.0,0,0.18440033217906543
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex,100,0.46013356198291944,2.6001409589521733,0.0,0,0.18440033217906543
T41 mutants of beta_catenin aren t phosphorylated,100,0.46013356198291944,2.6001409589521733,0.0,0,0.18440033217906543
S37 mutants of beta_catenin aren t phosphorylated,100,0.46013356198291944,2.6001409589521733,0.0,0,0.18440033217906543
Misspliced GSK3beta mutants stabilize beta_catenin,100,0.46013356198291944,2.6001409589521733,0.0,0,0.18440033217906543
Beta_catenin phosphorylation cascade,100,0.4118899395613672,2.0975839660673206,0.0,0,0.1688014121179624
Disassembly of the destruction complex and recruitment of AXIN to the membrane,100,0.3467513152449345,1.509866806443189,0.0,0,0.14650943908731479
Signaling by WNT in cancer,100,0.3467513152449345,4.093920563239153,0.0,0,0.14650943908731479
Spry regulation of FGF signaling,100,1.6498038472760743,21.39691955010629,0.5172413793103449,0,0.40395620828582646
Negative regulation of FGFR4 signaling,100,1.5248098428511252,18.291094174253455,0.3448275862068966,0,0.39116877850012427
Negative regulation of FGFR3 signaling,100,1.5543547498777375,18.87046271088501,0.41379310344827586,0,0.39433715170524636
Negative regulation of FGFR2 signaling,100,1.5543547498777375,18.87046271088501,0.41379310344827586,0,0.39433715170524636
Negative regulation of FGFR1 signaling,100,1.564178720799628,19.432025207204234,0.41379310344827586,0,0.39537009832812997
FGFR2 ligand binding and activation,100,-0.0,0.0,0.0,0,0.0
Activated point mutants of FGFR2,100,-0.0,0.0,0.0,0,0.0
FGFR1 ligand binding and activation,100,-0.0,0.0,0.0,0,0.0
SHC_mediated cascade:FGFR1,100,-0.0,0.0,0.0,0,0.0
SHC_mediated cascade:FGFR2,100,-0.0,0.0,0.0,0,0.0
SHC_mediated cascade:FGFR4,100,-0.0,0.0,0.0,0,0.0
SHC_mediated cascade:FGFR3,100,-0.0,0.0,0.0,0,0.0
Signaling by FGFR3 point mutants in cancer,550,0.09891558365260214,0.5243435759014986,0.0,0,0.02815395414545573
Signaling by FGFR3 in disease,550,0.09891558365260214,0.5243435759014986,0.0,0,0.02815395414545573
FGFR2 mutant receptor activation,100,0.3753453886262265,4.391461922503291,0.0,0,0.1564740310595324
Signaling by FGFR2 in disease,550,0.45522720397819383,4.218914796864523,0.0,0,0.10931941389224317
Signaling by FGFR in disease,550,0.429773376867024,4.222325712185699,0.0,0,0.10443101914824143
Signaling by FGFR1 in disease,150,0.15433019958775449,1.3847357547061157,0.0,0,0.06428197901057368
FGFR1 mutant receptor activation,1450,0.24510366540950773,2.896413585993901,0.0,0,0.04521250544202686
Signaling by cytosolic FGFR1 fusion mutants,1400,0.15312470608521508,0.6216278462236243,0.0,0,0.029942544121907843
PI3KslashAKT Signaling in Cancer,550,0.4421812125455,2.941187142673719,0.0,0,0.10682948298531326
Constitutive Signaling by Aberrant PI3K in Cancer,550,0.2245203185759768,1.3251484290519129,0.0,0,0.060116041567891076
PI5P PP2A and IER3 Regulate PI3KslashAKT Signaling,650,0.32992411335707894,2.373078947252432,0.0,0,0.07917197783474986
Negative regulation of the PI3KslashAKT network,750,0.41008497353024337,3.5234922257447225,0.0,0,0.08998154109322336
CLEC7A Dectin_1 signaling,700,0.8744768498826763,12.770738570460765,0.20689655172413793,600,0.15989018232902005
Downstream TCR signaling,600,1.4396213069476311,24.9439182573923,0.6551724137931034,150,0.2211870619494249
Metabolism of polyamines,1450,0.11306876044938924,0.43277176501208536,0.0,0,0.022236537829327604
Hedgehog  on  state,100,1.0419840013272044,13.99250583710476,0.20689655172413793,0,0.3236229387070856
Hedgehog  off  state,100,0.9279133068924982,15.005494499123971,0.20689655172413793,0,0.30231105876117875
TNFR2 non_canonical NF_kB pathway,550,0.7125800833933342,10.68806326645104,0.034482758620689655,550,0.15234409007556868
Degradation of beta_catenin by the destruction complex,100,0.8522051450149338,12.102327757273226,0.06896551724137931,0,0.2867632707667423
Antigen processing_Cross presentation,1450,1.5236181109417613,22.801565455983575,0.6206896551724138,0,0.16266565329381447
ER_Phagosome pathway,1450,1.6296708675656704,26.690203736713748,0.8275862068965517,0,0.16722647667124993
Autodegradation of Cdh1 by Cdh1:APCslashC,850,0.5400930185522145,7.51975156464222,0.0,0,0.10657860170956224
APCslashC:Cdc20 mediated degradation of Securin,850,0.6879750715870795,9.934719767880894,0.0,0,0.12703621551256208
APCslashC:Cdh1 mediated degradation of Cdc20 and other APCslashC:Cdh1 targeted proteins in late mitosisslashearly G1,850,0.6590550471469713,9.27992918496236,0.0,0,0.12326982492451116
APCslashC_mediated degradation of cell cycle proteins,850,0.5652904397797376,8.467457406737026,0.0,0,0.11028158759416329
Regulation of mitotic cell cycle,850,0.5652904397797376,8.467457406737026,0.0,0,0.11028158759416329
Regulation of APCslashC activators between G1slashS and early anaphase,850,0.6385410618831503,9.628860793419198,0.0,0,0.12053138209350028
Activation of APCslashC and APCslashC:Cdc20 mediated degradation of mitotic proteins,850,0.6827880955578833,9.670535159142176,0.0,0,0.12636868253195827
APCslashC:Cdc20 mediated degradation of mitotic proteins,850,0.6827880955578833,9.670535159142176,0.0,0,0.12636868253195827
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,850,0.6879750715870795,9.934719767880894,0.0,0,0.12703621551256208
Cdc20:Phospho_APCslashC mediated degradation of Cyclin A,850,0.6879750715870795,9.934719767880894,0.0,0,0.12703621551256208
Regulation of RAS by GAPs,900,0.6276206208888289,10.023911768967665,0.0,0,0.1165348630927448
Activation of NF_kappaB in B cells,550,0.9285595580237218,13.18172413295314,0.20689655172413793,550,0.18081912099196734
Dectin_1 mediated noncanonical NF_kB signaling,800,0.596325452884352,9.863661492224114,0.0,0,0.11732442734435473
NIK__>noncanonical NF_kB signaling,800,0.6495721554356909,10.505515520592242,0.0,0,0.12478514163579377
Degradation of GLI1 by the proteasome,100,1.1023264162917261,16.404885642658382,0.27586206896551724,0,0.3339512064638218
GLI3 is processed to GLI3R by the proteasome,800,0.7070678337156134,11.099268520665715,0.034482758620689655,800,0.132407405948955
Degradation of GLI2 by the proteasome,800,0.7070678337156134,11.099268520665715,0.034482758620689655,800,0.132407405948955
SCF_beta_TrCP mediated degradation of Emi1,800,0.791159918876012,12.32687688197329,0.10344827586206896,700,0.14279527985338156
Vpu mediated degradation of CD4,800,0.791159918876012,12.32687688197329,0.10344827586206896,700,0.14279527985338156
CDK_mediated phosphorylation and removal of Cdc6,800,0.8108417467566641,12.20984658792807,0.13793103448275862,550,0.14510299294078452
Ubiquitin_dependent degradation of Cyclin D1,800,0.8108417467566641,12.20984658792807,0.13793103448275862,550,0.14510299294078452
Ubiquitin_dependent degradation of Cyclin D,800,0.8108417467566641,12.20984658792807,0.13793103448275862,550,0.14510299294078452
Regulation of activated PAK_2p34 by proteasome mediated degradation,800,0.8108417467566641,12.20984658792807,0.13793103448275862,550,0.14510299294078452
Regulation of Apoptosis,800,0.8108417467566641,12.20984658792807,0.13793103448275862,550,0.14510299294078452
Autodegradation of the E3 ubiquitin ligase COP1,800,0.7758006678837199,11.392729680328237,0.034482758620689655,800,0.14096257405607537
Stabilization of p53,800,0.7265073675411882,10.676615086324196,0.034482758620689655,800,0.13488697039235722
p53_Independent DNA Damage Response,800,0.8108417467566641,12.20984658792807,0.13793103448275862,550,0.14510299294078452
p53_Independent G1slashS DNA damage checkpoint,800,0.8108417467566641,12.20984658792807,0.13793103448275862,550,0.14510299294078452
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,800,0.8108417467566641,12.20984658792807,0.13793103448275862,550,0.14510299294078452
Vif_mediated degradation of APOBEC3G,550,0.9008871074992104,13.186383317973261,0.20689655172413793,550,0.17750491827117856
AUF1 hnRNP D0 binds and destabilizes mRNA,800,0.8501092024502194,13.296249147358994,0.13793103448275862,700,0.1495736294833246
Degradation of AXIN,800,0.7758006678837199,11.392729680328237,0.034482758620689655,800,0.14096257405607537
Degradation of DVL,800,0.7638862080908,11.08038488047181,0.034482758620689655,800,0.1395213955275698
Hh mutants that don t undergo autocatalytic processing are degraded by ERAD,550,0.8994782003462041,15.20835416422147,0.2413793103448276,150,0.17733371386425753
Hh mutants abrogate ligand secretion,550,0.8994782003462041,15.20835416422147,0.2413793103448276,150,0.17733371386425753
Hedgehog ligand biogenesis,550,0.8444965456969665,14.479720939209937,0.20689655172413793,150,0.17046065455747964
The role of GTSE1 in G2slashM progression after G2 checkpoint,550,0.8994782003462041,13.476248830221476,0.20689655172413793,550,0.17733371386425753
Cross_presentation of soluble exogenous antigens endosomes,1450,0.2682314878386569,2.266541559620146,0.0,0,0.04893403009059214
Regulation of ornithine decarboxylase ODC,800,0.14836616593965876,0.9593406094677299,0.0,0,0.03601599708064019
G1slashS DNA Damage Checkpoints,800,0.6495721554356909,9.018956920798542,0.0,0,0.12478514163579377
p53_Dependent G1slashS DNA damage checkpoint,800,0.6495721554356909,9.018956920798542,0.0,0,0.12478514163579377
p53_Dependent G1 DNA Damage Response,800,0.6495721554356909,9.018956920798542,0.0,0,0.12478514163579377
SCFSkp2_mediated degradation of p27slashp21,100,0.5440777805065495,7.456866030905552,0.0,0,0.20981161430707745
Cyclin A:Cdk2_associated events at S phase entry,100,0.5025904882403807,5.188219847592534,0.0,0,0.19751925874186577
Cyclin E associated events during G1slashS transition,100,0.5099233478649607,5.476781273422525,0.0,0,0.19972919507768527
Synthesis of DNA,100,1.277593384569632,17.201595675252747,0.3448275862068966,0,0.360646382437551
DNA Replication Pre_Initiation,100,1.4294583506264955,20.668460884825283,0.4827586206896552,0,0.3802807105586947
MslashG1 Transition,100,1.4294583506264955,20.668460884825283,0.4827586206896552,0,0.3802807105586947
Regulation of DNA replication,100,1.4378565962067136,16.716108584407795,0.3103448275862069,0,0.38128193241388325
Removal of licensing factors from origins,100,1.4523090026424421,17.34678038645014,0.3793103448275862,0,0.38298535524865013
Switching of origins to a post_replicative state,100,1.4523090026424421,17.34678038645014,0.3793103448275862,0,0.38298535524865013
Orc1 removal from chromatin,100,1.4523090026424421,17.34678038645014,0.3793103448275862,0,0.38298535524865013
Assembly of the pre_replicative complex,100,1.4523090026424421,17.767632537192544,0.3793103448275862,0,0.38298535524865013
CDT1 association with the CDC6:ORC:origin complex,100,1.5248098428511252,20.522648918230136,0.4482758620689655,0,0.39116877850012427
Regulation of mRNA stability by proteins that bind AU_rich elements,800,0.8093120213224907,12.914855500840902,0.10344827586206896,700,0.14492525455782138
MAPK6slashMAPK4 signaling,800,0.6495721554356909,8.852333387027263,0.0,0,0.12478514163579377
Asymmetric localization of PCP proteins,800,0.7265073675411882,10.676615086324196,0.034482758620689655,800,0.13488697039235722
PCPslashCE pathway,800,0.7758006678837199,10.570358419210308,0.06896551724137931,700,0.14096257405607537
Deactivation of the beta_catenin transactivating complex,650,1.008918354582365,15.74413072405135,0.2413793103448276,0,0.17900693195293493
APCslashC:Cdc20 mediated degradation of Cyclin B,100,1.1023264162917261,15.824051788239801,0.1724137931034483,0,0.3339512064638218
Phosphorylation of the APCslashC,1300,0.1112860066141408,0.5694820442631178,0.0,0,0.022867441175626637
Conversion from APCslashC:Cdc20 to APCslashC:Cdh1 in late anaphase,1300,0.09410208933046647,0.4654382078817167,0.0,0,0.019500415433870093
Mitotic Spindle Checkpoint,1300,0.09410208933046647,0.4654382078817167,0.0,0,0.019500415433870093
Inhibition of the proteolytic activity of APCslashC required for the onset of anaphase by mitotic spindle checkpoint components,1300,0.09410208933046647,0.4654382078817167,0.0,0,0.019500415433870093
Inactivation of APCslashC via direct inhibition of the APCslashC complex,1300,0.09410208933046647,0.4654382078817167,0.0,0,0.019500415433870093
APC_Cdc20 mediated degradation of Nek2A,100,1.0661433803516636,15.1392568706961,0.13793103448275862,0,0.32783303751993753
Resolution of Sister Chromatid Cohesion,100,0.538014480501319,3.5346431621386603,0.0,0,0.20804677008342576
PTK6 Regulates RHO GTPases RAS GTPase and MAP kinases,150,0.26678072108813183,1.3126505552063048,0.0,0,0.10525207504842282
Signaling by PTK6,150,0.8421812749995375,9.77551604052957,0.06896551724137931,150,0.2558631045645067
ERBB2 Regulates Cell Motility,100,-0.0,0.0,0.0,0,0.0
PI3K events in ERBB2 signaling,550,0.24562673785431605,2.5219991998743883,0.0,0,0.0651038340360321
GRB2 events in ERBB2 signaling,100,-0.0,0.0,0.0,0,0.0
SHC1 events in ERBB2 signaling,100,-0.0,0.0,0.0,0,0.0
Signaling by ERBB2,550,1.7980103060496793,21.266190898624885,0.4827586206896552,0,0.24942303142787936
Constitutive Signaling by Ligand_Responsive EGFR Cancer Variants,550,1.1647266467063577,17.235466525555957,0.3448275862068966,0,0.2056649649060596
Signaling by Ligand_Responsive EGFR Variants in Cancer,550,1.1647266467063577,17.235466525555957,0.3448275862068966,0,0.2056649649060596
Signaling by EGFR in Cancer,550,1.1647266467063577,17.235466525555957,0.3448275862068966,0,0.2056649649060596
Signaling by EGFRvIII in Cancer,550,0.09167825973847765,0.46938199104215916,0.0,0,0.026187114653606014
Constitutive Signaling by EGFRvIII,550,0.09167825973847765,0.46938199104215916,0.0,0,0.026187114653606014
Tie2 Signaling,550,0.07539014955822486,0.30528211398193184,0.0,0,0.02170818806778215
TRAF6 mediated IRF7 activation,400,0.07886334576942171,0.3578812665183018,0.0,0,0.025277930987228563
RIG_IslashMDA5 mediated induction of IFN_alphaslashbeta pathways,500,1.2339635432599088,13.555851086682987,0.1724137931034483,500,0.21905091260245632
Negative regulators of RIG_IslashMDA5 signaling,500,1.347779931750811,16.070276651511737,0.3103448275862069,0,0.22872930176276657
Diseases associated with the TLR signaling cascade,500,0.20313301616691148,1.7274143034212885,0.0,0,0.05680669591440981
Diseases of Immune System,500,0.20313301616691148,1.7274143034212885,0.0,0,0.05680669591440981
Cytosolic sensors of pathogen_associated DNA,500,1.0385107040757076,14.039965809562972,0.1724137931034483,500,0.19963070360059398
ZBP1DAI mediated induction of type I IFNs,350,0.262474491825539,3.0245193702787336,0.0,0,0.08041372057604769
RIP_mediated NFkB activation via ZBP1,350,0.31851967318280605,4.059315007805775,0.0,0,0.09501619850719643
TRAF6 mediated NF_kB activation,400,0.621899099201536,8.505149056653261,0.0,0,0.15435873426726657
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,350,0.5650113661311852,7.57194644960633,0.0,0,0.15035599799320795
JNK c_Jun kinases phosphorylation and  activation mediated by activated human TAK1,250,0.17164585570172228,1.5443121803274942,0.0,0,0.061105815023877054
activated TAK1 mediates p38 MAPK activation,650,0.2953918287479855,3.0225020236138915,0.0,0,0.07205504472208084
NOD1slash2 Signaling Pathway,250,0.08768689654126803,0.1378120029460613,0.0,0,0.0325253138296436
Nucleotide_binding domain leucine rich repeat containing receptor NLR signaling pathways,450,0.06192419792432878,0.28813110292091204,0.0,0,0.019237328702505423
Interleukin_1 signaling,500,1.0522712026477024,16.02487973022098,0.2413793103448276,250,0.20112560461854648
MAP3K8 TPL2_dependent MAPK1slash3 activation,500,1.2339635432599088,23.07041433871184,0.6206896551724138,0,0.21905091260245632
MyD88_independent TLR3slashTLR4 cascade,250,1.3693018916254394,18.015331381967325,0.3793103448275862,150,0.28890952149667204
Toll Like Receptor 3 TLR3 Cascade,250,1.3693018916254394,18.015331381967325,0.3793103448275862,150,0.28890952149667204
TRIF_mediated TLR3slashTLR4 signaling,250,1.3693018916254394,18.015331381967325,0.3793103448275862,150,0.28890952149667204
MyD88:Mal cascade initiated on plasma membrane,250,1.6341234998285366,24.056184261434076,0.5517241379310345,0,0.3118300606788676
Toll Like Receptor TLR1:TLR2 Cascade,250,1.6341234998285366,24.056184261434076,0.5517241379310345,0,0.3118300606788676
Toll Like Receptor TLR6:TLR2 Cascade,250,1.6341234998285366,24.056184261434076,0.5517241379310345,0,0.3118300606788676
Toll Like Receptor 2 TLR2 Cascade,250,1.6341234998285366,24.056184261434076,0.5517241379310345,0,0.3118300606788676
Toll Like Receptor 9 TLR9 Cascade,250,1.5684421396029544,24.557017885809987,0.5862068965517241,0,0.30669813280836805
MyD88 dependent cascade initiated on endosome,250,1.571744446329412,25.213186329815958,0.6206896551724138,0,0.3069642809199148
Toll Like Receptor 7slash8 TLR7slash8 Cascade,250,1.571744446329412,25.213186329815958,0.6206896551724138,0,0.3069642809199148
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7slash8 or 9 activation,250,1.5837624160940842,25.759593954687105,0.6551724137931034,0,0.30792547867398157
Toll Like Receptor 10 TLR10 Cascade,250,1.5837624160940842,25.759593954687105,0.6551724137931034,0,0.30792547867398157
Toll Like Receptor 5 TLR5 Cascade,250,1.5837624160940842,25.759593954687105,0.6551724137931034,0,0.30792547867398157
MyD88 cascade initiated on plasma membrane,250,1.5837624160940842,25.759593954687105,0.6551724137931034,0,0.30792547867398157
TRAF6 Mediated Induction of proinflammatory cytokines,250,1.6341234998285366,26.334843627752587,0.6551724137931034,0,0.3118300606788676
MAP kinase activation in TLR cascade,250,1.571744446329412,21.810055367076256,0.5172413793103449,0,0.3069642809199148
MAPK targetsslash Nuclear events mediated by MAP kinases,150,0.6401371197048211,3.8867253330372518,0.0,0,0.21250970358950153
Nuclear Events kinase and transcription factor activation,150,0.7715515719336652,4.841697371877594,0.034482758620689655,150,0.24169277999015093
ERKslashMAPK targets,100,0.3612633268474407,1.4685234820562378,0.0,0,0.15160225532651328
Activation of IRF3slashIRF7 mediated by TBK1slashIKK epsilon,100,1.1023264162917261,12.614477574772542,0.13793103448275862,0,0.3339512064638218
IKK complex recruitment mediated by RIP1,100,0.9539156856404168,8.89737174784047,0.06896551724137931,0,0.3073851859060474
Caspase activation via extrinsic apoptotic signalig pathway,100,0.31949295489183327,1.1793482176652428,0.0,0,0.13674133962446633
Ligand_dependent caspase activation,100,-0.0,0.0,0.0,0,0.0
Regulated Necrosis,600,0.060865786312423474,0.22989196442370702,0.0,0,0.017118613127380056
RIPK1_mediated regulated necrosis,600,0.060865786312423474,0.22989196442370702,0.0,0,0.017118613127380056
TNFR1_induced NFkappaB signaling pathway,600,0.44586548433842743,3.780924860609316,0.0,0,0.1042850201700648
Regulation of TNFR1 signaling,650,1.213299494126546,16.89581286444871,0.3103448275862069,0,0.197994947892123
TNF signaling,600,1.6948996448802078,24.248336747268098,0.5862068965517241,150,0.23666756703164238
Death Receptor Signalling,600,1.4396213069476311,20.010812977708824,0.41379310344827586,150,0.2211870619494249
Anchoring of the basal body to the plasma membrane,1500,0.17504172905382404,0.5288478842592186,0.0,0,0.032952710247225084
Centrosome maturation,1500,0.46462989457204507,3.487895750315433,0.0,0,0.07626383042372072
Recruitment of mitotic centrosome proteins and complexes,1500,0.46462989457204507,3.487895750315433,0.0,0,0.07626383042372072
Loss of Nlp from mitotic centrosomes,1500,0.3782863993457584,1.3475537928389338,0.0,0,0.06463509074911102
Loss of proteins required for interphase microtubule organizationfrom the centrosome,1500,0.3782863993457584,1.3475537928389338,0.0,0,0.06463509074911102
AURKA Activation by TPX2,1500,0.3692480307933061,1.2545926380855337,0.0,0,0.06335873553042495
Regulation of PLK1 Activity at G2slashM Transition,1500,0.6155305789023667,6.808726483047421,0.0,0,0.09432535442906904
Polo_like kinase mediated events,300,0.2309789204165961,2.4538950656239433,0.0,0,0.07549047093844448
Cyclin AslashB1 associated events during G2slashM transition,100,0.46657317284353483,2.233818274183106,0.0,0,0.1864261415150547
WNT ligand biogenesis and trafficking,100,0.5799504295545335,5.84067110143639,0.0,0,0.22003693916762035
Negative regulation of TCF_dependent signaling by WNT ligand antagonists,100,-0.0,0.0,0.0,0,0.0
Regulation of FZD by ubiquitination,100,1.4523090026424421,24.257832057009875,0.6551724137931034,0,0.38298535524865013
Adherens junctions interactions,1300,0.04384142964281498,0.1926125729656837,0.0,0,0.009313605125383744
Cell_cell junction organization,100,-0.0,0.0,0.0,0,0.0
Cell junction organization,100,-0.0,0.0,0.0,0,0.0
Tight junction interactions,100,-0.0,0.0,0.0,0,0.0
Cell_extracellular matrix interactions,100,-0.0,0.0,0.0,0,0.0
Basigin interactions,400,0.15040099081950745,1.1244722572446626,0.0,0,0.04654569679427689
Nephrin interactions,900,1.7036628893256092,29.232204265640465,0.7241379310344828,200,0.20449610036552018
Netrin_1 signaling,1450,0.40658673954656366,5.211716158512182,0.0,0,0.06948597159104158
Regulation of KIT signaling,550,0.429773376867024,4.363572661883243,0.0,0,0.10443101914824143
CD209 DC_SIGN signaling,550,0.059167028186122086,0.20864193472282633,0.0,0,0.01717402276860403
Rap1 signalling,750,0.37887270561009984,4.6821739039936,0.0,0,0.0843540802148511
MAP2K and MAPK activation,750,0.5173861029060582,6.046747876462756,0.0,0,0.10804098382581248
GRB2:SOS provides linkage to MAPK signaling for Integrins,750,0.0798408939485916,0.481188983950822,0.0,0,0.02052546569885369
p130Cas linkage to MAPK signaling for integrins,750,0.09862940771772412,0.6707154656014923,0.0,0,0.025122036929870674
Integrin alphaIIb beta3 signaling,250,0.15911997711029927,1.445906833103763,0.0,0,0.05699266277952576
Platelet Aggregation Plug Formation,250,0.13742974540713288,0.8786693471297864,0.0,0,0.04974719572013697
Other semaphorin interactions,1450,0.013462298151163305,0.020773007789592353,0.0,0,0.0027812816587506894
Semaphorin interactions,1450,0.13133233722271842,0.5056187917724523,0.0,0,0.025598297283999448
CRMPs in Sema3A signaling,1350,0.21241215006547923,1.9531302394243468,0.0,0,0.04094117312965048
Sema3A PAK dependent Axon repulsion,550,0.5418776118307429,6.362235166387351,0.0,0,0.12505796682347958
Ephrin signaling,700,0.41218924690296777,4.201813873746658,0.0,0,0.09265608816516295
EPHB_mediated forward signaling,1300,0.24849992290471054,2.2044005871603267,0.0,0,0.047774971088709824
EPH_Ephrin signaling,1500,0.06752641796807776,0.2954277060508206,0.0,0,0.013399793930283463
EPH_ephrin mediated repulsion of cells,1500,0.011890053311795672,0.021447931946376765,0.0,0,0.0024255461415584774
EPHA_mediated growth cone collapse,550,0.04878422452959904,0.1409898407476459,0.0,0,0.014233312999269748
RHO GTPases activate PAKs,100,-0.0,0.0,0.0,0,0.0
RHO GTPases activate CIT,100,-0.0,0.0,0.0,0,0.0
RHO GTPases Activate ROCKs,1300,0.006637757050820758,0.010873486689618477,0.0,0,0.001436478590308286
Sema4D induced cell migration and growth_cone collapse,1300,0.06661885403998183,0.26453120763866833,0.0,0,0.013993609233311465
Sema4D in semaphorin signaling,1300,0.041107062745041556,0.15209832259230216,0.0,0,0.008744583239663385
Signaling by Robo receptor,1300,0.24126525792156744,3.3918774435043186,0.0,0,0.04654530670975915
Myogenesis,1300,0.258137557820311,2.0598164037903426,0.0,0,0.04939930607482265
CDO in myogenesis,1300,0.258137557820311,2.0598164037903426,0.0,0,0.04939930607482265
RHO GTPases Activate WASPs and WAVEs,200,0.8281299999030379,11.472677279076887,0.034482758620689655,200,0.23325796332256027
Regulation of actin dynamics for phagocytic cup formation,1050,1.3220515232922512,24.623281628694844,0.7241379310344828,150,0.1729594611229345
Role of phospholipids in phagocytosis,850,0.6661493483810028,9.340800562634051,0.0,0,0.12420385636947746
FCGR activation,1100,0.7015560504620288,11.327802519754474,0.034482758620689655,1100,0.11680116563499522
Classical antibody_mediated complement activation,100,-0.0,0.0,0.0,0,0.0
Creation of C4 and C2 activators,800,0.3742313133229862,4.183321116711485,0.0,0,0.08154320242241862
Initial triggering of complement,800,0.164427754402221,1.4603081817049555,0.0,0,0.039603980610793545
Complement cascade,800,0.02677715050881559,0.08216672568907714,0.0,0,0.006901482093308694
Binding and Uptake of Ligands by Scavenger Receptors,150,0.8311292431693157,8.353387714147082,0.034482758620689655,150,0.25371126761389684
Scavenging of heme from plasma,1500,0.5113701178845514,7.217029805154479,0.0,0,0.0821522626086323
FCERI mediated Ca+2 mobilization,200,0.11166819582074618,0.35048653001934355,0.0,0,0.04376540969921604
CD22 mediated BCR regulation,550,0.8994782003462041,13.578642699799643,0.13793103448275862,550,0.17733371386425753
Antigen activates B Cell Receptor BCR leading to generation of second messengers,550,1.2744023829393738,16.672274056818416,0.27586206896551724,200,0.21535342944813934
Regulation of Complement cascade,100,-0.0,0.0,0.0,0,0.0
Metabolism of Angiotensinogen to Angiotensins,1500,0.1987447283948457,0.3551944253910736,0.0,0,0.03698778742716176
Regulation of Insulin_like Growth Factor IGF transport and uptake by Insulin_like Growth Factor Binding Proteins IGFBPs,1500,0.22406768733542354,0.22406768733542354,0.0,0,0.041194265001430135
Synthesis secretion and inactivation of Glucagon_like Peptide_1 GLP_1,1300,0.19916782766262173,1.1186804817037628,0.0,0,0.039210862602057216
Incretin synthesis secretion and inactivation,1300,0.19916782766262173,1.1186804817037628,0.0,0,0.039210862602057216
Synthesis secretion and deacylation of Ghrelin,850,0.06175282478281467,0.3249504771333858,0.0,0,0.015294377884748385
Peptide hormone metabolism,1500,0.29872515644688025,1.0271620889779571,0.0,0,0.052993562954026324
Insulin processing,1400,0.20721537083133287,0.9468848832645342,0.0,0,0.03947046709826304
VxPx cargo_targeting to cilium,1000,0.10327910854654868,1.378469578707174,0.0,0,0.023574780623259774
Cargo trafficking to the periciliary membrane,1400,0.048689856648882854,0.1297426806704675,0.0,0,0.010022552871124184
BBSome_mediated cargo_targeting to cilium,1400,0.08643598895339341,0.23458969842070704,0.0,0,0.017463459667273126
Cooperation of PDCL PhLP1 and TRiCslashCCT in G_protein beta folding,100,-0.0,0.0,0.0,0,0.0
Chaperonin_mediated protein folding,100,0.014069746324164249,0.014069746324164249,0.0,0,0.006985615008856638
Association of TriCslashCCT with target proteins during biosynthesis,100,0.2144824194002059,1.7553395558978133,0.0,0,0.09652050078480173
Prefoldin mediated transfer of substrate  to CCTslashTriC,1450,0.0025420970913750105,0.0025420970913750105,0.0,0,0.0005280633539958145
Cooperation of Prefoldin and TriCslashCCT  in actin and tubulin folding,1450,9.378691037146673e-05,9.378691037146673e-05,0.0,0,1.9505974503390025e-05
Formation of tubulin folding intermediates by CCTslashTriC,100,-0.0,0.0,0.0,0,0.0
Post_chaperonin tubulin folding pathway,900,0.17527365287130403,1.7038981850461112,0.0,0,0.04019316690649616
Regulation of signaling by CBL,550,1.1647266467063577,13.690943187635787,0.2413793103448276,550,0.2056649649060596
GPVI_mediated activation cascade,550,1.2595818261652039,17.909523965602286,0.41379310344827586,300,0.2141054779598508
G beta:gamma signalling through PI3Kgamma,550,0.9285595580237218,14.05034502616483,0.27586206896551724,300,0.18081912099196734
G_protein beta:gamma signalling,550,1.1647266467063577,15.707183199511459,0.27586206896551724,300,0.2056649649060596
Class Bslash2 Secretin family receptors,250,0.15911997711029927,0.6234908781846724,0.0,0,0.05699266277952576
Ca2+ pathway,1300,0.05665708067825765,0.31337252807258265,0.0,0,0.011959904957273938
Activation of Kainate Receptors upon glutamate binding,550,0.07539014955822486,0.30528211398193184,0.0,0,0.02170818806778215
Presynaptic function of Kainate receptors,550,0.09167825973847765,0.46938199104215916,0.0,0,0.026187114653606014
G beta:gamma signalling through PLC beta,550,0.09167825973847765,0.46938199104215916,0.0,0,0.026187114653606014
Prostacyclin signalling through prostacyclin receptor,100,-0.0,0.0,0.0,0,0.0
ADP signalling through P2Y purinoceptor 12,100,-0.0,0.0,0.0,0,0.0
G_protein activation,100,-0.0,0.0,0.0,0,0.0
Adrenalinenoradrenaline inhibits insulin secretion,100,-0.0,0.0,0.0,0,0.0
Signal amplification,100,-0.0,0.0,0.0,0,0.0
ADP signalling through P2Y purinoceptor 1,100,-0.0,0.0,0.0,0,0.0
Thromboxane signalling through TP receptor,100,-0.0,0.0,0.0,0,0.0
Thrombin signalling through proteinase activated receptors PARs,100,-0.0,0.0,0.0,0,0.0
Glucagon_type ligand receptors,100,-0.0,0.0,0.0,0,0.0
Glucagon_like Peptide_1 GLP1 regulates insulin secretion,100,-0.0,0.0,0.0,0,0.0
Regulation of insulin secretion,1300,0.1176096912103375,0.773454713408024,0.0,0,0.024092015736448712
Opioid Signalling,550,0.9008871074992104,12.063721169459637,0.20689655172413793,550,0.17750491827117856
Glucagon signaling in metabolic regulation,100,-0.0,0.0,0.0,0,0.0
Vasopressin regulates renal water homeostasis via Aquaporins,100,-0.0,0.0,0.0,0,0.0
Aquaporin_mediated transport,100,-0.0,0.0,0.0,0,0.0
G alpha z signalling events,1300,0.06661885403998183,0.25347462116085756,0.0,0,0.013993609233311465
GABA receptor activation,100,-0.0,0.0,0.0,0,0.0
GABA B receptor activation,100,-0.0,0.0,0.0,0,0.0
Activation of GABAB receptors,100,-0.0,0.0,0.0,0,0.0
Activation of G protein gated Potassium channels,1350,0.004141942728426253,0.00423572963879772,0.0,0,0.0008842895266395859
Inhibition  of voltage gated Ca2+ channels via Gbetaslashgamma subunits,1350,0.004141942728426253,0.00423572963879772,0.0,0,0.0008842895266395859
G protein gated Potassium channels,1350,0.004141942728426253,0.00423572963879772,0.0,0,0.0008842895266395859
Inwardly rectifying K+ channels,100,-0.0,0.0,0.0,0,0.0
Potassium Channels,650,0.25080133068857263,1.7829875909958424,0.0,0,0.06249399469669979
Voltage gated Potassium channels,550,0.5913196740978677,6.489031354335691,0.0,0,0.13344574692244482
Activation of NMDA receptor upon glutamate binding and postsynaptic events,250,0.5649818963306656,5.088767209273276,0.0,0,0.16722446646974143
Post NMDA receptor activation events,250,0.5649818963306656,5.088767209273276,0.0,0,0.16722446646974143
CREB phosphorylation through the activation of Ras,250,0.6203638363522241,6.730173704558463,0.0,0,0.1790881006314308
Ras activation uopn Ca2+ infux through NMDA receptor,100,-0.0,0.0,0.0,0,0.0
CREB phosphorylation through the activation of CaMKII,150,0.4946755204348049,5.087653591761598,0.0,0,0.17540495196792177
Unblocking of NMDA receptor glutamate binding and activation,100,-0.0,0.0,0.0,0,0.0
SALM protein interactions at the synapse,1300,0.06661885403998183,0.30368428369842926,0.0,0,0.013993609233311465
Phospholipase C_mediated cascade: FGFR1,150,0.2667668328994158,1.3953754134276461,0.0,0,0.1052472941775314
Phospholipase C_mediated cascade FGFR2,150,0.25578540812710243,1.259358477801099,0.0,0,0.10144618904811388
Phospholipase C_mediated cascade FGFR3,150,0.25578540812710243,1.259358477801099,0.0,0,0.10144618904811388
Phospholipase C_mediated cascade FGFR4,150,0.24558350506263313,1.1631154911982546,0.0,0,0.09787730871879709
EGFR interacts with phospholipase C_gamma,150,0.26678072108813183,1.5771817628449731,0.0,0,0.10525207504842282
DAG and IP3 signaling,150,0.26678072108813183,1.5771817628449731,0.0,0,0.10525207504842282
PLC_gamma1 signalling,150,0.26678072108813183,1.5771817628449731,0.0,0,0.10525207504842282
CaM pathway,150,0.3144244906311349,2.683693382679368,0.0,0,0.12126828922522714
Calmodulin induced events,150,0.3144244906311349,2.683693382679368,0.0,0,0.12126828922522714
Ca_dependent events,150,0.30288891406574203,2.317442637932442,0.0,0,0.11746014316600818
PLC beta mediated events,150,0.21786393903655812,2.277459349944692,0.0,0,0.08799442278750318
G_protein mediated events,150,0.21786393903655812,2.277459349944692,0.0,0,0.08799442278750318
PKA_mediated phosphorylation of CREB,150,0.38077415994487945,3.445254911201261,0.0,0,0.14233892977856466
PKA activation,100,-0.0,0.0,0.0,0,0.0
PKA activation in glucagon signalling,100,-0.0,0.0,0.0,0,0.0
The phototransduction cascade,100,0.46013356198291944,2.99641236905046,0.0,0,0.18440033217906543
Inactivation recovery and regulation of the phototransduction cascade,100,0.46013356198291944,2.99641236905046,0.0,0,0.18440033217906543
Smooth Muscle Contraction,700,0.5761618933797978,6.786279120925244,0.0,0,0.1201257346457195
Striated Muscle Contraction,100,-0.0,0.0,0.0,0,0.0
Ion homeostasis,400,0.06832403750476052,0.24147680321837392,0.0,0,0.022014070937307045
Ion transport by P_type ATPases,400,0.23944570398500048,1.8027346863819425,0.0,0,0.07097866445968844
Platelet calcium homeostasis,800,0.022208875981511732,0.06149524065678553,0.0,0,0.005737101369292728
Elevation of cytosolic Ca2+ levels,800,0.08825742960905116,0.5720860578837682,0.0,0,0.022065154735214986
Platelet homeostasis,800,0.14836616593965876,1.0508278335693093,0.0,0,0.03601599708064019
Nitric oxide stimulates guanylate cyclase,650,0.21365666278444514,2.0521293746866873,0.0,0,0.05419744917498416
cGMP effects,650,0.21365666278444514,2.0521293746866873,0.0,0,0.05419744917498416
Phase 2 _ plateau phase,100,-0.0,0.0,0.0,0,0.0
Phase 1 _ inactivation of fast Na+ channels,100,-0.0,0.0,0.0,0,0.0
Phase 0 _ rapid depolarisation,100,-0.0,0.0,0.0,0,0.0
NCAM1 interactions,100,-0.0,0.0,0.0,0,0.0
Class Cslash3 Metabotropic glutamateslashpheromone receptors,550,0.3909205841436619,5.8477736518426955,0.0,0,0.09672526734780026
Chemokine receptors bind chemokines,200,0.3821587089890405,2.984656194429811,0.0,0,0.13155971834871652
Nucleotide_like purinergic receptors,1300,0.01619298460498649,0.030362898499334712,0.0,0,0.0034876569777061964
Eicosanoid ligand_binding receptors,100,-0.0,0.0,0.0,0,0.0
Amine ligand_binding receptors,1500,0.019604152474939174,0.019604152474939174,0.0,0,0.003983851223928079
eNOS activation and regulation,100,-0.0,0.0,0.0,0,0.0
Metabolism of nitric oxide,100,-0.0,0.0,0.0,0,0.0
Scavenging by Class A Receptors,100,0.6190216590044628,6.506531306779883,0.0,0,0.2307645058888359
Chylomicron_mediated lipid transport,100,-0.0,0.0,0.0,0,0.0
Lipoprotein metabolism,1350,0.004141942728426253,0.0046941828705945,0.0,0,0.0008842895266395859
HDL_mediated lipid transport,1350,0.06181481005152305,0.20512580958221915,0.0,0,0.012824140244472728
Lipid digestion mobilization and transport,1350,0.01825001460124857,0.029070957075294168,0.0,0,0.003868973861980491
Hormone_sensitive lipase HSL_mediated triacylglycerol hydrolysis,1300,0.04384142964281498,0.20440296446066455,0.0,0,0.009313605125383744
Digestion of dietary lipid,100,-0.0,0.0,0.0,0,0.0
Inositol phosphate metabolism,750,0.2693312316573415,3.354842792250483,0.0,0,0.0631543902226191
Synthesis of IP3 and IP4 in the cytosol,550,0.0711427945445924,0.4178503789097729,0.0,0,0.02052820288554934
Synthesis of PIPs at the plasma membrane,800,1.1645103592411927,16.51673163174044,0.41379310344827586,550,0.1796885635028252
PI Metabolism,800,0.7638862080908,9.547052898624123,0.034482758620689655,800,0.1395213955275698
Synthesis of PIPs at the Golgi membrane,1400,0.09966260455189027,0.2737263782743687,0.0,0,0.020005081492247053
p75 NTR receptor_mediated signalling,100,1.419377561596742,8.458634550598074,0.10344827586206896,0,0.3790677420914732
Cell death signalling via NRAGE NRIF and NADE,100,1.1023264162917261,8.558034322889215,0.06896551724137931,0,0.3339512064638218
NRAGE signals death through JNK,100,-0.0,0.0,0.0,0,0.0
G alpha 12slash13 signalling events,100,-0.0,0.0,0.0,0,0.0
Signaling by Hippo,550,0.8994782003462041,14.047197638786715,0.13793103448275862,550,0.17733371386425753
Apoptotic execution  phase,950,0.5452190543762269,7.469862092638283,0.0,0,0.10295539140388799
Apoptotic cleavage of cellular proteins,100,0.2817007627368496,3.722903201227906,0.0,0,0.12275028745028743
Mitochondrial protein import,700,0.4801000695799808,5.6887351467218235,0.0,0,0.10458160580857588
TGF_beta receptor signaling in EMT epithelial to mesenchymal transition,100,1.1023264162917261,17.3739677766001,0.3103448275862069,0,0.3339512064638218
TGF_beta receptor signaling activates SMADs,100,1.4294583506264955,19.146526124527963,0.41379310344827586,0,0.3802807105586947
Downregulation of TGF_beta receptor signaling,100,1.4860760283123968,21.544466628835615,0.5172413793103449,0,0.38687062558777763
Signaling by BMP,1500,0.029774279747351636,0.029774279747351636,0.0,0,0.00602000672535179
Signaling by NODAL,100,-0.0,0.0,0.0,0,0.0
Inflammasomes,800,0.164427754402221,1.3339723742330185,0.0,0,0.039603980610793545
Ligand_gated ion channel transport,100,-0.0,0.0,0.0,0,0.0
ROS RNS production in response to bacteria,250,0.43301878302843866,3.0265858386219167,0.0,0,0.13616148264265046
Insulin receptor recycling,250,0.5649818963306656,5.474927725832627,0.0,0,0.16722446646974143
Transferrin endocytosis and recycling,250,0.4964442345745914,4.432549842763077,0.0,0,0.15160316682819772
Iron uptake and transport,250,0.7040844800430777,6.887989479273882,0.034482758620689655,250,0.19582009555385915
TRP channels,100,-0.0,0.0,0.0,0,0.0
Effects of PIP2 hydrolysis,400,0.10019964914118873,0.9418631306380754,0.0,0,0.031781071315118904
Synthesis of PC,250,0.6828707412071996,10.552106902520912,0.0,0,0.19171200037159514
Synthesis of PA,100,-0.0,0.0,0.0,0,0.0
Acyl chain remodelling of PG,1100,0.10029599286586105,0.7301830789037695,0.0,0,0.022107635568527084
Acyl chain remodelling of PC,450,0.13775638949060795,1.2007859817974638,0.0,0,0.041229050351547204
Acyl chain remodelling of PE,550,0.16113837166513037,1.5340267927607367,0.0,0,0.04448922781110374
Acyl chain remodelling of PS,100,-0.0,0.0,0.0,0,0.0
Acyl chain remodelling of PI,100,-0.0,0.0,0.0,0,0.0
Mitochondrial Fatty Acid Beta_Oxidation,850,0.26767123094358686,3.608452963855488,0.0,0,0.05997756152701134
Diseases of metabolism,500,1.3824937576821452,22.95885334284457,0.6551724137931034,0,0.23146857435806237
Defects in vitamin and cofactor metabolism,200,0.270403731318291,2.5969041641464545,0.0,0,0.09813905752115477
Cobalamin Cbl vitamin B12 transport and metabolism,200,0.270403731318291,2.5969041641464545,0.0,0,0.09813905752115477
Metabolism of water_soluble vitamins and cofactors,200,0.0009239348076014971,0.0009239348076014971,0.0,0,0.00038252958464566787
Metabolism of folate and pterines,100,-0.0,0.0,0.0,0,0.0
Sulfur amino acid metabolism,100,-0.0,0.0,0.0,0,0.0
Metabolism of steroid hormones,1000,0.060876304237024025,0.463906474283049,0.0,0,0.014189437130255006
Steroid hormones,1000,0.052046319437096394,0.3465624892641633,0.0,0,0.01218445972569214
Amine_derived hormones,550,0.6845466376491656,11.307140455969158,0.0,0,0.14817649631215474
Peroxisomal lipid metabolism,1200,0.4170133583942167,4.3230434169557,0.0,0,0.07638443585200577
Synthesis of very long_chain fatty acyl_CoAs,100,-0.0,0.0,0.0,0,0.0
Fatty Acyl_CoA Biosynthesis,950,0.07876512561952703,0.47830885180065524,0.0,0,0.01855442821317144
Triglyceride Biosynthesis,1300,0.03909209493091602,0.12358725671839345,0.0,0,0.008324271481806584
Transcriptional regulation of white adipocyte differentiation,250,0.12452227423172456,1.011566065573273,0.0,0,0.045360367222942295
Mitochondrial biogenesis,400,0.6076065745780364,8.037861828666292,0.0,0,0.15178236787044266
Transcriptional activation of mitochondrial biogenesis,250,0.2925772824318251,2.483470544856094,0.0,0,0.09827539418582551
Circadian Clock,150,0.7911287755806219,9.40469420570955,0.034482758620689655,150,0.24572130119223606
BMAL1:CLOCKNPAS2 activates circadian gene expression,250,0.30603435135951756,1.8018978404063781,0.0,0,0.10214044782021295
RORA activates gene expression,250,0.13316442681173474,0.4154776208959929,0.0,0,0.048303812463693384
YAP1_ and WWTR1 TAZ_stimulated gene expression,1000,0.29145823117691455,3.7632790801432594,0.0,0,0.06074241056096723
Regulation of cholesterol biosynthesis by SREBP SREBF,700,0.6744985105193168,11.472145167701349,0.0,0,0.13456435640017017
Activation of gene expression by SREBF SREBP,550,0.2893389560922576,3.8006039834735765,0.0,0,0.07510493901848374
Cholesterol biosynthesis,950,0.12170051017340655,1.345389858396273,0.0,0,0.02806974237808866
Nuclear Receptor transcription pathway,400,0.6076065745780364,6.212398732353254,0.0,0,0.15178236787044266
Recycling of bile acids and salts,1000,0.10327910854654868,0.927704784072097,0.0,0,0.023574780623259774
Bile acid and bile salt metabolism,1000,0.009557878634581095,0.009557878634581095,0.0,0,0.0022853706709922658
Synthesis of bile acids and bile salts,1000,0.019744948441709532,0.04952059081899734,0.0,0,0.004697258377780652
Synthesis of bile acids and bile salts via 7alpha_hydroxycholesterol,1000,0.019744948441709532,0.04952059081899734,0.0,0,0.004697258377780652
Synthesis of bile acids and bile salts via 27_hydroxycholesterol,1000,0.052046319437096394,0.29664980526173357,0.0,0,0.01218445972569214
Arachidonic acid metabolism,100,-0.0,0.0,0.0,0,0.0
Synthesis of Leukotrienes LT and Eoxins EX,1300,0.0283896613782629,0.09112653167826835,0.0,0,0.006077548572067578
Fatty acids,100,-0.0,0.0,0.0,0,0.0
Endogenous sterols,1000,0.37203622094493194,3.330131065984941,0.0,0,0.07463959674258512
Cytochrome P450 _ arranged by substrate type,1000,0.1704254887217434,1.264456781519127,0.0,0,0.03764623355369493
Phase 1 _ Functionalization of compounds,150,0.19310109032253167,1.5306071312772598,0.0,0,0.07893101409290426
Xenobiotics,100,-0.0,0.0,0.0,0,0.0
Aflatoxin activation and detoxification,100,-0.0,0.0,0.0,0,0.0
Glutathione conjugation,400,0.07886334576942171,0.3578812665183018,0.0,0,0.025277930987228563
Glucuronidation,950,0.21211002604683415,2.0827397584376093,0.0,0,0.04681886652375169
Cytosolic sulfonation of small molecules,600,0.522386264853105,6.933828547602486,0.0,0,0.11795844444456673
Synthesis and interconversion of nucleotide di_ and triphosphates,850,0.01564434451909877,0.027976454860431814,0.0,0,0.003964424154037878
Detoxification of Reactive Oxygen Species,400,0.23944570398500048,1.6021284975271946,0.0,0,0.07097866445968844
Metabolism of porphyrins,100,-0.0,0.0,0.0,0,0.0
Purine metabolism,1450,0.28015183498973056,2.593555458278632,0.0,0,0.05081879565158868
Metabolism of nucleotides,1500,0.07639060972091961,0.20306402418386615,0.0,0,0.015092550279679717
Pyrimidine metabolism,1300,0.006637757050820758,0.010873486689618477,0.0,0,0.001436478590308286
Complex I biogenesis,350,0.9827631667029075,16.003863971696305,0.1724137931034483,300,0.2179595453651576
Respiratory electron transport,1300,1.3193893308525095,24.10071882546357,0.6896551724137931,0,0.15909094766368753
Formation of ATP by chemiosmotic coupling,350,1.4098584973859434,29.84675181908497,1.0,0,0.2632766522190941
Glyoxylate metabolism and glycine degradation,400,1.2874409263403253,17.998888998284883,0.3793103448275862,200,0.24134129219198683
Pyruvate metabolism,400,0.27792390215813334,2.3815177455910983,0.0,0,0.08088184921304369
Pyruvate metabolism and Citric Acid TCA cycle,650,0.3823517332744223,4.980863443202035,0.0,0,0.08951798489724412
Citric acid cycle TCA cycle,950,0.35176109544506506,4.187519397735373,0.0,0,0.07264497881163115
Histidine lysine phenylalanine tyrosine proline and tryptophan catabolism,800,0.11151849658615313,0.80728152046074,0.0,0,0.027563578995329564
Mitochondrial tRNA aminoacylation,1150,1.2604013685816324,21.77984479114984,0.5862068965517241,300,0.16315938978524896
tRNA Aminoacylation,1450,1.9548387847919464,27.11747440798798,0.6896551724137931,550,0.17854262775731894
Cytosolic tRNA aminoacylation,850,0.6378979976124152,7.648446384017528,0.0,0,0.12044462707485817
tRNA modification in the nucleus and cytosol,1300,0.258137557820311,3.7742188631430733,0.0,0,0.04939930607482265
Branched_chain amino acid catabolism,950,0.35176109544506506,4.175747039426327,0.0,0,0.07264497881163115
Phase 4 _ resting membrane potential,1350,0.06181481005152305,0.20512580958221915,0.0,0,0.012824140244472728
Mitochondrial translation initiation,100,-0.0,0.0,0.0,0,0.0
Mitochondrial translation termination,100,-0.0,0.0,0.0,0,0.0
Mitochondrial translation,100,-0.0,0.0,0.0,0,0.0
Mitochondrial translation elongation,100,-0.0,0.0,0.0,0,0.0
